GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a tough sell, too. Now, researchers at the Massachusetts Institute of Technology (MIT) say they’ve developed an… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
Published on December 4, 2024
Take the stairs. Tote heavy shopping bags. Walk up that hill. Play tag with a kid or a pet.Weaving these tiny bursts of vigorous physical activity into everyday life can halve a woman’s risk of a heart attack, a new study shows.An average of four daily minutes of this sort… Read Full Article (External Site) […]
Published on December 4, 2024
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk’s Wegovy in the first large, head-to-head trial of the highly in-demand rival medicines. In the 751-person trial, Zepbound helped patients lose… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]
Published on December 4, 2024